Statement by Dr Alan Howard, National Medical Director, KetaMIND : SASOP has issued three position statements since 2022 outlining their stance on a current hot topic; administration of low dose ketamine infusion for Treatment Resistant Depression (TRD)
November 22, 2024November 22, 2024